These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 37497018)

  • 21. Economic Burden of Herpes Zoster ("culebrilla") in Latin America.
    Rampakakis E; Pollock C; Vujacich C; Toniolo Neto J; Ortiz Covarrubias A; Monsanto H; Johnson KD
    Int J Infect Dis; 2017 May; 58():22-26. PubMed ID: 28267595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases.
    Koltsov JCB; Sambare TD; Alamin TF; Wood KB; Cheng I; Hu SS
    Spine J; 2022 Jun; 22(6):965-974. PubMed ID: 35123048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
    King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
    Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.
    White RR; Lenhart G; Singhal PK; Insinga RP; Itzler RF; Pellissier JM; Segraves AW
    Pharmacoeconomics; 2009; 27(9):781-92. PubMed ID: 19757871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
    van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
    Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.
    Schoepfer A; Vavricka SR; Brüngger B; Reich O; Blozik E; Bähler C
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):868-875. PubMed ID: 29757772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study.
    Côté-Daigneault J; Bessissow T; Nicolae MV; Nie R; Bitton A; Lakatos PL; Brassard P
    Inflamm Bowel Dis; 2019 Apr; 25(5):914-918. PubMed ID: 30295818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
    Soh H; Chun J; Han K; Park S; Choi G; Kim J; Lee J; Im JP; Kim JS
    Gut Liver; 2019 May; 13(3):333-341. PubMed ID: 30602222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P043 Resource Utilization and Productivity Loss among Patients with Inflammatory Bowel Disease in Sweden: A Longitudinal Nationwide Population-based Study.
    Cai Q; Sanon M; Batyrbekova N; Di Scala L; Kavanagh S
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S11. PubMed ID: 37461961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis.
    Curran D; Hunjan M; El Ghachi A; El-Hahi Y; Bianco V; Ferreira G
    BMJ Open; 2019 Aug; 9(8):e023502. PubMed ID: 31462457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in Nationwide Herpes Zoster Emergency Department Utilization From 2006 to 2013.
    Dommasch ED; Joyce CJ; Mostaghimi A
    JAMA Dermatol; 2017 Sep; 153(9):874-881. PubMed ID: 28636704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.
    Kappelman MD; Rifas-Shiman SL; Porter CQ; Ollendorf DA; Sandler RS; Galanko JA; Finkelstein JA
    Gastroenterology; 2008 Dec; 135(6):1907-13. PubMed ID: 18854185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Risk of Herpes Zoster Infection in Patients With Inflammatory Bowel Diseases in Korea.
    Chang K; Lee HS; Kim YJ; Kim SO; Kim SH; Lee SH; Song EM; Hwang SW; Park SH; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1928-1936.e2. PubMed ID: 29857150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nationwide temporal trends in incidence of hospitalization and surgical intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997 to 2009.
    Debruyn JC; Soon IS; Hubbard J; Wrobel I; Panaccione R; Kaplan GG
    Inflamm Bowel Dis; 2013 Oct; 19(11):2423-32. PubMed ID: 23974991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing thirty-day readmissions of Crohn's disease and ulcerative colitis in the United States: A national dilemma.
    Dahiya DS; Perisetti A; Kichloo A; Singh A; Goyal H; Rotundo L; Vennikandam M; Shaka H; Singh G; Singh J; Pisipati S; Al-Haddad M; Sanaka MR; Inamdar S
    World J Gastrointest Pathophysiol; 2022 May; 13(3):85-95. PubMed ID: 35720163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn's Disease or Ulcerative Colitis in the United States.
    Ding Z; Muser E; Izanec J; Lukanova R; Kershaw J; Roughley A
    Crohns Colitis 360; 2022 Jul; 4(3):otac023. PubMed ID: 36777416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic.
    Velez FF; Anastassopoulos KP; Colman S; Shah N; Kauffman L; Murphy SM; Ruetsch C; Maricich YA
    Adv Ther; 2022 Sep; 39(9):4131-4145. PubMed ID: 35799080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015.
    Vadstrup K; Alulis S; Borsi A; Gustafsson N; Nielsen A; Wennerström ECM; Jørgensen TR; Qvist N; Munkholm P
    Inflamm Bowel Dis; 2020 Aug; 26(9):1377-1382. PubMed ID: 31693731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.